Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission ...

Robert W. Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock ...

A month has gone by since the last earnings report for Catalent (CTLT). Shares have added about 3.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Catalent, Inc. (“Catalent”) and Novo Holdings A/S (“Novo Holdings”) jointly announced today the unconditional approval granted by the European Commission (EC) for the pending acquisition transaction ...

Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $61.84 which represents a slight increase of $0.14 or 0.23% from the prior close of $61.7. The stock opened at $61.75 and touched a low ...

Comcast investors are reacting after management said it expects the company's broadband subscribers to decline by over 100,000 in the current quarter. The major market indexes (^DJI, ^IXIC ...

Highlights,State Street Corp increased its stake in Catalent by 1.5% in Q3.,Catalent reported a slight miss on earnings in ...

Catalent, Inc. (NYSE:CTLT – Get Free Report) has been assigned an average rating of “Hold” from the seven research firms that ...

There are no important events for this country at this time. Select "All" to see top events in other countries or view all events.

Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors?